A New Validation of the Spanish Work Productivity and Activity Impairment Questionnaire—Crohn's Disease Version-Reference-Cited by-同舟云学术

A New Validation of the Spanish Work Productivity and Activity Impairment Questionnaire—Crohn's Disease Version

Published:2011-09 Issue:6 Volume:14 Page:859-861
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Vergara Mercedes,Montserrat Antònia,Casellas Francesc,Villoria Albert,Suarez David,Maudsley Michael,Gallardo Olga,Ricart Elena,Calvet Xavier

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference11 articles.

1. The validity and accuracy of the Work Productivity and Activity Impairment questionnaire-irritable bowel syndrome version (WPAI:IBS);Reilly;Aliment Pharmacol Ther,2004

2. Clinical trial: the effects of certolizumab pegol therapy on work productivity in patients with moderate-to-severe Crohn's disease in the PRECiSE 2 study;Feagan;Pharmacol Ther,2010

3. Validity, reliability, and responsiveness of the work productivity and activity impairment questionnaire in Crohn's disease;Reilly;Clin Ther,2008

4. Validation of the Spanish Work Productivity and Activity Impairment Questionnaire—Crohn's disease version;Vergara;Eur J Gastroenterol Hepatol,2009

5. Assessment of disease activity in ulcerative colitis and Crohn's disease activity;Hodgson;Inflamm Bowel Dis,1995

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of the inflammatory bowel disease objective disability index (IBDODI);2023-07-12

2. Validation and meaningful within-patient change in work productivity and activity impairment questionnaire (WPAI) for episodic or chronic migraine;Journal of Patient-Reported Outcomes;2023-04-04

3. Withdrawal of Anti-Tumour Necrosis Factor in Inflammatory Bowel Disease Patients in Remission: A Randomised Placebo-Controlled Clinical Trial of GETECCU;2023

4. Improvement of Work Productivity and Quality of Life with Anti-Tumor Necrosis Factor Treatment Used in Crohn’s Disease in Routine Clinical Practice in Turkey;Turkish Journal of Gastroenterology;2022-05-26

5. Quality of Life and Work Productivity Improvements with Upadacitinib: Phase 2b Evidence from Patients with Moderate to Severe Crohn’s Disease;Advances in Therapy;2021-03-23